A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Clinical trial NCT06311578 · RECRUITING
Trial details
- NCT number
- NCT06311578
- Sponsor
- Johnson & Johnson Enterprise Innovation Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2028-11-08
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.